Reduced Risk?

A genome-wide association study identifies a SNP that could help explain the relatively low rates of breast cancer among Latina women.

Written byMolly Sharlach
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Digital mammogram imagesWIKIMEDIA, NEVIT DILMEN

Latina women in the United States have a less than 10 percent lifetime risk of developing breast cancer, while the rate is about 13 percent for non-Hispanic white women and 11 percent for black women. A new genetic analysis of more than 11,000 women has uncovered a single-nucleotide polymorphism (SNP) upstream of an estrogen receptor gene that may contribute to this decreased risk. The study, published this week (October 20) in Nature Communications, is the first of its kind to use genetic information from Latina women.

About 20 percent of Latina women in the U.S. carry one copy of the protective allele, while 1 percent carry two copies—these were associated with 40 percent and 80 percent decreases in the risk of breast cancer, respectively. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies